M
GLUE//CIK 0001826457
Monte Rosa Therapeutics, Inc.
Market Data
$17.34−$0.46 (−2.58%)
GLUE · Last trade
Prev Close
$17.80
Range (30d)
$14.72 – $17.66
Recent Filings
- 10-K35.8 MBMonte Rosa Therapeutics, Inc.Mar 17, 7:14 AM ET·0001193125-26-109360
- 8-K516.5 KBMonte Rosa Therapeutics, Inc.Mar 17, 7:04 AM ET·0001193125-26-109353
- 8-K168.1 KBMonte Rosa Therapeutics, Inc.Feb 10, 4:01 PM ET·0001193125-26-044616
- 8-K677.1 KBMonte Rosa Therapeutics, Inc.Jan 9, 4:32 PM ET·0001193125-26-009005
- 8-K169.0 KBMonte Rosa Therapeutics, Inc.Jan 7, 4:17 PM ET·0001193125-26-006341
- 8-K14.0 MBMonte Rosa Therapeutics, Inc.Jan 7, 7:06 AM ET·0001193125-26-005420
- 8-K12.2 MBMonte Rosa Therapeutics, Inc.Dec 16, 7:30 AM ET·0001193125-25-319981
- 10-Q12.2 MBMonte Rosa Therapeutics, Inc.Nov 6, 7:05 AM ET·0001193125-25-268045
- 8-K500.4 KBMonte Rosa Therapeutics, Inc.Nov 6, 7:03 AM ET·0001193125-25-268042
- 8-K215.5 KBMonte Rosa Therapeutics, Inc.Sep 15, 7:01 AM ET·0001193125-25-202760
Insiders
10- BASKETT FOREST10% Owner
- Behbahani AliDirector, 10% Owner
- Blackwell KimberlyDirector
- Bolzon Bradley J PhDDirector, 10% Owner
- Bowen MatthewPrincipal Accounting Officer
- Castle John C.Chief Data Scientist
- Champoux JenniferChief Operating Officer
- Chang Carmen10% Owner
- Chen Bihua10% Owner
- Cormorant Asset Management, LPFormer 10% Owner
Tickers
Addresses
business
321 HARRISON AVENUE SUITE 900
BOSTON, MA, 02118
mailing
321 HARRISON AVENUE SUITE 900
BOSTON, MA, 02118
Former Names
- Monte Rosa Therapeutics, Inc.2026-03-17